These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Nickell SP; Sharma D Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388 [TBL] [Abstract][Full Text] [Related]
24. Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Sun J; Tarleton RL Am J Trop Med Hyg; 1993 Feb; 48(2):161-9. PubMed ID: 8447518 [TBL] [Abstract][Full Text] [Related]
25. Chagas' disease: a clinical, parasitological, immunological, and pathological study in rabbits. Teixeira AR; Figueiredo F; Rezende Filho J; Macêdo V Am J Trop Med Hyg; 1983 Mar; 32(2):258-72. PubMed ID: 6404186 [TBL] [Abstract][Full Text] [Related]
26. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096 [TBL] [Abstract][Full Text] [Related]
27. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. Nickell SP; Stryker GA; Arevalo C J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987 [TBL] [Abstract][Full Text] [Related]
29. Innate and acquired immunity in the pathogenesis of Chagas disease. Golgher D; Gazzinelli RT Autoimmunity; 2004 Aug; 37(5):399-409. PubMed ID: 15621564 [TBL] [Abstract][Full Text] [Related]
30. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Martin D; Tarleton R Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249 [TBL] [Abstract][Full Text] [Related]
31. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126 [TBL] [Abstract][Full Text] [Related]
32. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile. Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249 [TBL] [Abstract][Full Text] [Related]
33. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease. Michailowsky V; Luhrs K; Rocha MO; Fouts D; Gazzinelli RT; Manning JE Infect Immun; 2003 Jun; 71(6):3165-71. PubMed ID: 12761095 [TBL] [Abstract][Full Text] [Related]
34. Disease Tolerance and Pathogen Resistance Genes May Underlie Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E Front Immunol; 2018; 9():2791. PubMed ID: 30559742 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans. Amezcua Vesely MC; Rodríguez C; Gruppi A; Acosta Rodríguez EV Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165706. PubMed ID: 31987839 [TBL] [Abstract][Full Text] [Related]
36. Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens. Silva AA; Roffe E; Marino AP; dos Santos PV; Quirico-Santos T; Paiva CN; Lannes-Vieira J Clin Immunol; 1999 Jul; 92(1):56-66. PubMed ID: 10413653 [TBL] [Abstract][Full Text] [Related]
38. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768 [TBL] [Abstract][Full Text] [Related]
39. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease. Teixeira AR; Teixeira G; Macêdo V; Prata A Am J Trop Med Hyg; 1978 Nov; 27(6):1097-1107. PubMed ID: 83110 [TBL] [Abstract][Full Text] [Related]
40. Chagas cardiomyopathy is associated with a high susceptibility to T. cruzi infection in monocyte-derived macrophages and a predominance of CD4 Carvalho AMRS; Ferraz IA; Hojo-Souza NS; Medeiros FAC; Viana LA; Bartholomeu DC; Chaves AT; de Souza TM; Costa E Silva MF; Mendes TAO; Duarte MC; Rocha MODC; Menezes-Souza D Acta Trop; 2023 Jan; 237():106749. PubMed ID: 36370753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]